
Search Results for compounds
Searching compounds for 5z 137 6 returned 943 results.
Displaying compounds 401 - 425 of 943 in total
T3D2587
59392-53-9
disodium (2S,3R,4R,4aS,5aR,6aS,7aS,8R,9R,10R,11aR,12R,12aR,13aS,14aR)-10-[(2R,3R,4R,4aS,6S,7R,8aS)-6-[(1R,3R)-4-[(2S,3R,4R,4aS,6R,7R,8aS)-6-[(1R,3S,5R,7S,9R,10R,12R,13S,14S,16R,19S,21R,23S,25S,28R,30S)-25-[(1S,3R,5S,7R,9S,11S,14R,16S,18R,20S,21Z,24R,26S,28R,30S,32R,34R,35R,37S,39R,42S,44R)-11-[(1S,2R,4R,5S)-1,2-dihydroxy-4,5-dimethyloct-7-en-1-yl]-35-hydroxy-14,16,18,32,34,39,42,44-octamethyl-2,6,10,15,19,25,29,33,38,43-decaoxadecacyclo[22.21.0.0³,²⁰.0⁵,¹⁸.0⁷,¹⁶.0⁹,¹⁴.0²⁶,⁴⁴.0²⁸,⁴².0³⁰,³⁹.0³²,³⁷]pentatetracont-21-en-34-yl]-9,13-dihydroxy-3,7,14,19,30-pentamethyl-2,6,11,15,20,24,29-heptaoxaheptacyclo[17.12.0.0³,¹⁶.0⁵,¹⁴.0⁷,¹².0²¹,³⁰.0²³,²⁸]hentriacontan-10-yl]-3,4,7-trihydroxy-octahydropyrano[3,2-b]pyran-2-yl]-1,3-dihydroxybutyl]-3,4,7-trihydroxy-octahydropyrano[3,2-b]pyran-2-yl]-2-[(2S,3R)-2,3-dihydroxy-3-[(1S,3R,5S,6S,7R,8S,10R,11R,13S,15R,17S,19R,21R,22S,24S,25S,26R)-6,7,11,21,25-pentahydroxy-13,17-dimethyl-8-[(2R,3R,4R,7S,8R,9R,11R,13E)-3,8,11,15-tetrahydroxy-4,9,13-trimethyl-12-methylidene-7-(sulfonatooxy)pentadec-13-en-2-yl]-4,9,14,18,23,27-hexaoxahexacyclo[13.12.0.0³,¹³.0⁵,¹⁰.0¹⁷,²⁶.0¹⁹,²⁴]heptacosan-22-yl]propyl]-4,8,9,12-tetrahydroxy-hexadecahydro-2H-1,5,7,11,13-pentaoxapentacen-3-yl sulfate
T3D2701
65-23-6
4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol
Matched synonyms: … 5-Hydroxy-6-methyl-3,4-pyridinedimethanol …
T3D2771
24584-09-6
6-hydroxy-4-[(2S)-2-(5-hydroxy-3-oxo-1,2,3,6-tetrahydropyrazin-1-yl)propyl]-2,3,4,5-tetrahydropyrazin-2-one
T3D4764
114-07-8
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione
T3D2455
2552-55-8
(2S)-2-amino-2-(3-hydroxy-1,2-oxazol-5-yl)acetic acid
Matched symptoms: … ), and altered sensory perception. These effects generally last for 6-8 hours, varying with dose. (L1141) …
T3D3092
4678-45-9
5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecane-3,4,6,9,14,16-hexol
Matched synonyms: … (3-beta,6-beta,14R)-Grayanotoxane-3,5,6,10,14,16-hexol …
T3D3104
56073-07-5
2-hydroxy-3-[3-(4-phenylphenyl)-1,2,3,4-tetrahydronaphthalen-1-yl]-4H-chromen-4-one
Matched treatment: … slow intravenous injections of 10-25 mg repeated all 3-6 hours until normalisation of the prothrombin …
T3D3553
7789-18-6
T3D3559
10544-72-6
T3D3763
73561-91-8
2,3,23,23,25,25-hexamethyl-8-(prop-1-en-2-yl)-7,24-dioxa-31-azaoctacyclo[15.14.0.0²,¹⁵.0³,¹².0⁶,¹¹.0¹⁸,³⁰.0²⁰,²⁸.0²²,²⁷]hentriaconta-1(17),10,18(30),19,26,28-hexaene-9,12-diol
Matched synonyms: … ,10,12,15,15b,15c,16,17,17a-hexadecahydro-4bH-chromeno[5',6':6,7]indeno[1,2-b]pyrano[4',3':3,4]cyclopen ta[1,2-f]indole-3,4b-diol …
T3D3770
71376-34-6
T3D3851
117337-19-6
methyl 2-[(2-chloro-4-fluoro-5-{[(1Z)-3-oxo-hexahydro-[1,3,4]thiadiazolo[3,4-a]pyridazin-1-ylidene]amino}phenyl)sulfanyl]acetate
T3D3920
28434-00-6
(1S)-2-methyl-4-oxo-3-(prop-2-en-1-yl)cyclopent-2-en-1-yl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropane-1-carboxylate
T3D1263
892-20-6
T3D2566
9005-49-6
(2R,3S,4S,5R)-3-{[(2S,3R,4S,5S,6S)-5-{[(2R,3R,4R,5S,6S)-6-carboxy-5-{[(2R,3R,4R,5S,6R)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-[(sulfooxy)methyl]oxan-2-yl]oxy}-3,4-dihydroxyoxan-2-yl]oxy}-6-hydroxy-4-(sulfomethyl)-3-(sulfooxy)oxan-2-yl]oxy}-4,6-dihydroxy-5-(sulfooxy)oxane-2-carboxylic acid
T3D2742
2180-92-9
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboximidic acid
Matched toxicity: … arterial plasma concentration of 4.5 mcg/mL.
LD50: 6 to 8 mg/kg (intravenous, mice)
LD50: 38 to 54 mg/kg (subcutaneous, mice) …
Matched synonyms: … 1-Butyl-2',6'-pipecoloxylidide ... dl-1-Butyl-2',6'-pipecoloxylidide …
Matched synonyms: … 1-Butyl-2',6'-pipecoloxylidide ... dl-1-Butyl-2',6'-pipecoloxylidide …
T3D2788
18883-66-4
(2S,3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)-N-methyl-N-nitrosooxane-3-carbamimidic acid
T3D3101
56073-10-0
3-{3-[4-(4-bromophenyl)phenyl]-1,2,3,4-tetrahydronaphthalen-1-yl}-2-hydroxy-4H-chromen-4-one
Matched treatment: … slow intravenous injections of 10-25 mg repeated all 3-6 hours until normalisation of the …